Checkpoint Capital »

SPDR S&P Biotech shares owned by Checkpoint Capital

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Checkpoint Capital from 13F filings

Historical chart of Checkpoint Capital investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Checkpoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Checkpoint Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 180k 89.29

More positions owned by Checkpoint Capital

Rhythm Pharmaceuticals (RYTM)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Axsome Therapeutics (AXSM)
Mirum Pharmaceuticals (MIRM)
Protagonist Therapeutics (PTGX)
Corcept Therapeutics Incorporated (CORT)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Phathom Pharmaceuticals (PHAT)
Atyr Pharma Com New (LIFE)
Verastem Com New (VSTM)
Gh Research Ordinary Shares (GHRS)
Trevi Therapeutics (TRVI)
Applied Therapeutics (APLT)

View all positions for Checkpoint Capital

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Susquehanna International
Citadel Advisors
Bank of America Corporation
Citigroup
Jpmorgan Chase & Co
Morgan Stanley
Millennium Management
venBio Select Advisor
Bnp Paribas Arbitrage, Snc
UBS Group
Healthcare Of Ontario Pension Plan Trust Fund
Soleus Capital Management
Capital Fund Management
Wells Fargo & Company

View all funds holding SPDR S&P Biotech